Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 57 | 2023 | 1352 | 9.950 |
Why?
|
Hematopoiesis | 55 | 2023 | 2073 | 7.150 |
Why?
|
Hematologic Neoplasms | 28 | 2023 | 1832 | 4.760 |
Why?
|
Thalidomide | 17 | 2024 | 890 | 4.660 |
Why?
|
Leukemia, Myeloid, Acute | 47 | 2024 | 3524 | 4.620 |
Why?
|
Hematopoietic Stem Cells | 45 | 2023 | 3390 | 3.930 |
Why?
|
Mutation | 89 | 2024 | 29786 | 3.260 |
Why?
|
Myeloproliferative Disorders | 16 | 2022 | 606 | 2.800 |
Why?
|
Chromosomes, Human, Pair 5 | 18 | 2022 | 403 | 2.560 |
Why?
|
Ubiquitin-Protein Ligases | 16 | 2024 | 1862 | 2.450 |
Why?
|
Dioxygenases | 14 | 2024 | 316 | 2.410 |
Why?
|
Tumor Suppressor Protein p53 | 29 | 2024 | 2949 | 2.350 |
Why?
|
Ribosomal Proteins | 15 | 2019 | 360 | 2.350 |
Why?
|
Chromosome Deletion | 19 | 2022 | 1401 | 2.070 |
Why?
|
Erythropoiesis | 15 | 2020 | 706 | 2.010 |
Why?
|
Precancerous Conditions | 7 | 2023 | 975 | 2.000 |
Why?
|
Janus Kinase 2 | 16 | 2023 | 528 | 1.870 |
Why?
|
Anemia, Diamond-Blackfan | 13 | 2021 | 137 | 1.840 |
Why?
|
Ribosomes | 6 | 2013 | 500 | 1.630 |
Why?
|
Clone Cells | 8 | 2019 | 1692 | 1.630 |
Why?
|
Neoplastic Stem Cells | 10 | 2018 | 1376 | 1.610 |
Why?
|
Leukemia | 10 | 2022 | 1510 | 1.570 |
Why?
|
Casein Kinase Ialpha | 5 | 2021 | 27 | 1.570 |
Why?
|
Ubiquitination | 10 | 2024 | 1012 | 1.500 |
Why?
|
Anemia, Macrocytic | 7 | 2019 | 55 | 1.320 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 260 | 1.300 |
Why?
|
Casein Kinase I | 4 | 2018 | 47 | 1.300 |
Why?
|
Neoplasms, Second Primary | 5 | 2022 | 1062 | 1.250 |
Why?
|
Point Mutation | 7 | 2018 | 1624 | 1.240 |
Why?
|
Blood | 3 | 2022 | 598 | 1.220 |
Why?
|
Haploinsufficiency | 7 | 2022 | 328 | 1.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2020 | 5445 | 1.140 |
Why?
|
Multiple Myeloma | 10 | 2024 | 5181 | 1.140 |
Why?
|
Spliceosomes | 3 | 2018 | 110 | 1.100 |
Why?
|
Chromosome Aberrations | 13 | 2022 | 1813 | 1.080 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2022 | 670 | 1.070 |
Why?
|
Humans | 283 | 2024 | 744366 | 1.020 |
Why?
|
Erythroid Precursor Cells | 6 | 2016 | 218 | 1.020 |
Why?
|
Mice | 98 | 2023 | 81201 | 1.010 |
Why?
|
Animals | 141 | 2023 | 168768 | 1.010 |
Why?
|
Erythroid Cells | 10 | 2017 | 239 | 0.990 |
Why?
|
DNA Damage | 7 | 2023 | 2432 | 0.950 |
Why?
|
DNA-Binding Proteins | 24 | 2024 | 9647 | 0.900 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2015 | 789 | 0.900 |
Why?
|
Bone Marrow Neoplasms | 2 | 2014 | 104 | 0.890 |
Why?
|
Bone Marrow | 14 | 2023 | 2948 | 0.880 |
Why?
|
Fetal Hemoglobin | 3 | 2015 | 341 | 0.870 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2022 | 22 | 0.870 |
Why?
|
Proto-Oncogene Proteins | 14 | 2022 | 4554 | 0.860 |
Why?
|
Peptide Termination Factors | 1 | 2022 | 55 | 0.850 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 2 | 2022 | 97 | 0.840 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2020 | 2943 | 0.820 |
Why?
|
Cyclins | 2 | 2023 | 603 | 0.810 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2021 | 1381 | 0.810 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2021 | 119 | 0.760 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 74 | 0.760 |
Why?
|
RNA Interference | 8 | 2016 | 2890 | 0.740 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 193 | 0.730 |
Why?
|
Hydroxyurea | 4 | 2015 | 289 | 0.730 |
Why?
|
Anemia, Sickle Cell | 5 | 2015 | 1020 | 0.720 |
Why?
|
Primary Myelofibrosis | 5 | 2017 | 215 | 0.720 |
Why?
|
Polymerization | 1 | 2020 | 164 | 0.720 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2021 | 5172 | 0.720 |
Why?
|
Polycythemia Vera | 5 | 2013 | 164 | 0.710 |
Why?
|
Aging | 6 | 2022 | 8664 | 0.710 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 292 | 0.700 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2021 | 66 | 0.700 |
Why?
|
Cell Differentiation | 22 | 2021 | 11486 | 0.700 |
Why?
|
Gene Deletion | 6 | 2020 | 2751 | 0.700 |
Why?
|
RNA Splicing | 4 | 2021 | 908 | 0.690 |
Why?
|
Genomics | 11 | 2023 | 5717 | 0.690 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 294 | 0.670 |
Why?
|
Antineoplastic Agents | 16 | 2023 | 13693 | 0.670 |
Why?
|
Neoplasms | 22 | 2022 | 21696 | 0.660 |
Why?
|
Antisickling Agents | 3 | 2015 | 80 | 0.660 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15160 | 0.660 |
Why?
|
Atherosclerosis | 6 | 2023 | 3444 | 0.660 |
Why?
|
Phosphoproteins | 6 | 2020 | 2441 | 0.650 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2020 | 671 | 0.650 |
Why?
|
Cell Line, Tumor | 32 | 2023 | 16690 | 0.650 |
Why?
|
Transcription Factors | 15 | 2024 | 12207 | 0.640 |
Why?
|
src-Family Kinases | 1 | 2021 | 551 | 0.640 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2021 | 735 | 0.630 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.630 |
Why?
|
Leukemia, Experimental | 2 | 2017 | 246 | 0.630 |
Why?
|
Ikaros Transcription Factor | 4 | 2020 | 217 | 0.630 |
Why?
|
Sequence Deletion | 7 | 2018 | 1525 | 0.610 |
Why?
|
Erythroblasts | 2 | 2015 | 150 | 0.610 |
Why?
|
Epigenesis, Genetic | 12 | 2021 | 3646 | 0.610 |
Why?
|
Histone Deacetylase 2 | 2 | 2015 | 74 | 0.610 |
Why?
|
Stem Cell Niche | 5 | 2016 | 346 | 0.590 |
Why?
|
gamma-Globins | 2 | 2015 | 95 | 0.590 |
Why?
|
Histone Deacetylase 1 | 2 | 2015 | 137 | 0.580 |
Why?
|
Disease Models, Animal | 26 | 2022 | 18034 | 0.580 |
Why?
|
Purines | 1 | 2020 | 594 | 0.570 |
Why?
|
Bone Marrow Cells | 10 | 2016 | 2513 | 0.570 |
Why?
|
Calgranulin A | 2 | 2019 | 79 | 0.570 |
Why?
|
Cell Cycle | 5 | 2023 | 2967 | 0.570 |
Why?
|
Nuclear Proteins | 14 | 2022 | 5856 | 0.570 |
Why?
|
Mutation, Missense | 7 | 2021 | 2566 | 0.570 |
Why?
|
Repressor Proteins | 10 | 2021 | 3024 | 0.560 |
Why?
|
DNA Mutational Analysis | 13 | 2020 | 4185 | 0.560 |
Why?
|
Pancytopenia | 2 | 2019 | 104 | 0.550 |
Why?
|
RNA Precursors | 2 | 2015 | 209 | 0.540 |
Why?
|
Selection, Genetic | 3 | 2020 | 914 | 0.540 |
Why?
|
CLOCK Proteins | 1 | 2016 | 88 | 0.540 |
Why?
|
Base Sequence | 18 | 2018 | 12797 | 0.530 |
Why?
|
K562 Cells | 6 | 2021 | 635 | 0.530 |
Why?
|
Gout | 1 | 2022 | 573 | 0.530 |
Why?
|
Calgranulin B | 1 | 2016 | 84 | 0.530 |
Why?
|
ARNTL Transcription Factors | 1 | 2016 | 99 | 0.530 |
Why?
|
Ribonucleoproteins | 2 | 2015 | 381 | 0.520 |
Why?
|
Leucine | 3 | 2014 | 560 | 0.520 |
Why?
|
Genetic Predisposition to Disease | 15 | 2022 | 17446 | 0.520 |
Why?
|
Gene Expression Regulation | 19 | 2019 | 12073 | 0.510 |
Why?
|
Review Literature as Topic | 1 | 2017 | 336 | 0.510 |
Why?
|
Erythropoietin | 13 | 2010 | 726 | 0.500 |
Why?
|
DNA Repair | 2 | 2022 | 2046 | 0.500 |
Why?
|
Alleles | 7 | 2020 | 6933 | 0.500 |
Why?
|
Anemia | 4 | 2022 | 1503 | 0.490 |
Why?
|
Cell Cycle Proteins | 5 | 2021 | 3464 | 0.490 |
Why?
|
Chromatin | 2 | 2023 | 2933 | 0.480 |
Why?
|
Prognosis | 24 | 2022 | 29060 | 0.480 |
Why?
|
Hematology | 1 | 2017 | 221 | 0.480 |
Why?
|
Ascorbic Acid | 1 | 2017 | 651 | 0.470 |
Why?
|
Mice, Knockout | 16 | 2021 | 14561 | 0.470 |
Why?
|
Protein Kinase Inhibitors | 10 | 2019 | 5534 | 0.460 |
Why?
|
HLA Antigens | 1 | 2019 | 1382 | 0.460 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.460 |
Why?
|
Integrin beta3 | 2 | 2013 | 122 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2021 | 2504 | 0.460 |
Why?
|
ras Proteins | 3 | 2017 | 1060 | 0.450 |
Why?
|
Mice, Mutant Strains | 6 | 2021 | 1865 | 0.450 |
Why?
|
Telomere | 3 | 2020 | 910 | 0.430 |
Why?
|
Exons | 5 | 2019 | 2439 | 0.420 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 494 | 0.420 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2024 | 2917 | 0.410 |
Why?
|
Mice, Inbred C57BL | 18 | 2021 | 21833 | 0.410 |
Why?
|
MicroRNAs | 10 | 2020 | 3751 | 0.410 |
Why?
|
Osteoporosis | 1 | 2021 | 1579 | 0.410 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2021 | 2938 | 0.410 |
Why?
|
Hemoglobin, Sickle | 1 | 2012 | 122 | 0.410 |
Why?
|
Lymphoma | 3 | 2021 | 1877 | 0.400 |
Why?
|
Genes, Neurofibromatosis 1 | 2 | 2013 | 79 | 0.390 |
Why?
|
Proteins | 7 | 2023 | 6100 | 0.390 |
Why?
|
Dexamethasone | 2 | 2011 | 1951 | 0.390 |
Why?
|
Pyridines | 2 | 2020 | 2825 | 0.380 |
Why?
|
STAT Transcription Factors | 4 | 2018 | 182 | 0.380 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3707 | 0.380 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2725 | 0.380 |
Why?
|
Antigens, CD34 | 7 | 2017 | 659 | 0.380 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2012 | 3921 | 0.380 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2011 | 80 | 0.380 |
Why?
|
Lipomatosis | 1 | 2011 | 112 | 0.380 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 587 | 0.370 |
Why?
|
Signal Transduction | 17 | 2021 | 23404 | 0.370 |
Why?
|
Small Molecule Libraries | 4 | 2020 | 720 | 0.370 |
Why?
|
Enzyme Inhibitors | 3 | 2018 | 3799 | 0.370 |
Why?
|
Amino Acid Substitution | 5 | 2013 | 1793 | 0.360 |
Why?
|
Ligands | 7 | 2023 | 3282 | 0.360 |
Why?
|
HEK293 Cells | 10 | 2022 | 4208 | 0.360 |
Why?
|
Inflammasomes | 4 | 2023 | 495 | 0.360 |
Why?
|
Gene Expression Profiling | 19 | 2016 | 9445 | 0.360 |
Why?
|
Quinazolines | 2 | 2017 | 1356 | 0.350 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 2021 | 189 | 0.350 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1596 | 0.350 |
Why?
|
Bone Marrow Diseases | 1 | 2011 | 231 | 0.350 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10183 | 0.350 |
Why?
|
Isoxazoles | 9 | 1998 | 216 | 0.350 |
Why?
|
Fanconi Anemia | 2 | 2023 | 319 | 0.350 |
Why?
|
Hematologic Diseases | 1 | 2013 | 498 | 0.340 |
Why?
|
Pyrimidines | 5 | 2019 | 2943 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 8432 | 0.340 |
Why?
|
Angiogenesis Inhibitors | 3 | 2017 | 2038 | 0.340 |
Why?
|
Anemia, Aplastic | 1 | 2011 | 226 | 0.330 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1415 | 0.330 |
Why?
|
Megakaryocytes | 7 | 2019 | 545 | 0.330 |
Why?
|
Transcription, Genetic | 14 | 2020 | 7721 | 0.330 |
Why?
|
Tumor Cells, Cultured | 15 | 2021 | 6313 | 0.320 |
Why?
|
Inflammation | 8 | 2023 | 10637 | 0.320 |
Why?
|
Genome, Human | 3 | 2020 | 4420 | 0.320 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2020 | 1335 | 0.320 |
Why?
|
RNA, Small Interfering | 9 | 2017 | 3505 | 0.320 |
Why?
|
Mesenchymal Stem Cells | 4 | 2017 | 1632 | 0.320 |
Why?
|
Aminopyridines | 3 | 2022 | 542 | 0.320 |
Why?
|
Cell Hypoxia | 10 | 2008 | 675 | 0.310 |
Why?
|
Open Reading Frames | 1 | 2011 | 811 | 0.310 |
Why?
|
Models, Biological | 11 | 2020 | 9584 | 0.310 |
Why?
|
Janus Kinases | 4 | 2019 | 244 | 0.310 |
Why?
|
DNA Modification Methylases | 2 | 2022 | 206 | 0.310 |
Why?
|
Neoplasm, Residual | 4 | 2022 | 973 | 0.300 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2021 | 290 | 0.300 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2023 | 1520 | 0.300 |
Why?
|
Transplantation, Homologous | 4 | 2020 | 4777 | 0.300 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2020 | 1581 | 0.300 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 1965 | 0.300 |
Why?
|
Cell Lineage | 9 | 2017 | 2504 | 0.290 |
Why?
|
Gene Dosage | 4 | 2017 | 1252 | 0.290 |
Why?
|
Telomerase | 1 | 2012 | 730 | 0.290 |
Why?
|
Plaque, Atherosclerotic | 1 | 2018 | 1519 | 0.290 |
Why?
|
Genes, p53 | 5 | 2022 | 755 | 0.290 |
Why?
|
Survival Analysis | 8 | 2020 | 10252 | 0.290 |
Why?
|
Male | 60 | 2024 | 350115 | 0.290 |
Why?
|
Female | 62 | 2024 | 380193 | 0.290 |
Why?
|
Jurkat Cells | 2 | 2021 | 743 | 0.290 |
Why?
|
Phenotype | 18 | 2020 | 16367 | 0.280 |
Why?
|
Transplantation, Autologous | 5 | 2023 | 2124 | 0.280 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2012 | 451 | 0.280 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1758 | 0.280 |
Why?
|
Disease Susceptibility | 3 | 2023 | 1782 | 0.270 |
Why?
|
Transplantation Conditioning | 3 | 2020 | 1599 | 0.270 |
Why?
|
Gene Silencing | 4 | 2014 | 1539 | 0.270 |
Why?
|
Peptide Hydrolases | 3 | 2018 | 634 | 0.270 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9735 | 0.270 |
Why?
|
Aged | 34 | 2024 | 163288 | 0.260 |
Why?
|
Cell Proliferation | 14 | 2021 | 10483 | 0.260 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4463 | 0.260 |
Why?
|
RNA, Messenger | 9 | 2015 | 13035 | 0.260 |
Why?
|
DNA Methylation | 4 | 2022 | 4285 | 0.260 |
Why?
|
Interleukin-3 | 2 | 2022 | 444 | 0.260 |
Why?
|
Substrate Specificity | 3 | 2019 | 1802 | 0.260 |
Why?
|
Middle Aged | 39 | 2024 | 213390 | 0.250 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 182 | 0.250 |
Why?
|
Genomic Instability | 3 | 2020 | 695 | 0.250 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 1097 | 0.250 |
Why?
|
Leukemia, Myeloid | 3 | 2020 | 707 | 0.240 |
Why?
|
Drugs, Investigational | 2 | 2021 | 214 | 0.240 |
Why?
|
Phthalimides | 1 | 2024 | 25 | 0.240 |
Why?
|
Adult | 37 | 2023 | 214052 | 0.240 |
Why?
|
Cell Death | 3 | 2022 | 1707 | 0.240 |
Why?
|
Bone Marrow Transplantation | 5 | 2014 | 2765 | 0.240 |
Why?
|
Piperidones | 1 | 2024 | 28 | 0.240 |
Why?
|
Metabolic Diseases | 1 | 2011 | 658 | 0.240 |
Why?
|
Thrombosis | 1 | 2018 | 2968 | 0.240 |
Why?
|
Mevalonic Acid | 1 | 2024 | 42 | 0.240 |
Why?
|
Apoptosis | 9 | 2023 | 9724 | 0.230 |
Why?
|
Receptors, AMPA | 8 | 1998 | 332 | 0.230 |
Why?
|
Remission Induction | 3 | 2020 | 2385 | 0.230 |
Why?
|
Mice, Inbred NOD | 5 | 2021 | 1879 | 0.230 |
Why?
|
Blood Platelet Disorders | 1 | 2023 | 58 | 0.230 |
Why?
|
Interleukin-7 | 1 | 2023 | 142 | 0.220 |
Why?
|
Molecular Sequence Data | 18 | 2015 | 18111 | 0.220 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2023 | 345 | 0.220 |
Why?
|
Cell Survival | 8 | 2020 | 5882 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2540 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2021 | 3554 | 0.220 |
Why?
|
Proteome | 4 | 2021 | 1798 | 0.220 |
Why?
|
Flow Cytometry | 9 | 2016 | 5974 | 0.220 |
Why?
|
Biomedical Research | 1 | 2018 | 3309 | 0.220 |
Why?
|
Germ-Line Mutation | 5 | 2023 | 1788 | 0.220 |
Why?
|
Structure-Activity Relationship | 9 | 2023 | 3130 | 0.220 |
Why?
|
Azacitidine | 3 | 2014 | 347 | 0.210 |
Why?
|
Blood Physiological Phenomena | 1 | 2022 | 55 | 0.210 |
Why?
|
Mosaicism | 2 | 2022 | 441 | 0.210 |
Why?
|
Coronary Disease | 1 | 2017 | 6077 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 1434 | 0.210 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 29 | 0.210 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.210 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2023 | 431 | 0.210 |
Why?
|
Genetic Linkage | 1 | 2008 | 2421 | 0.210 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1707 | 0.210 |
Why?
|
Heart Failure | 3 | 2024 | 10895 | 0.210 |
Why?
|
L-Lactate Dehydrogenase | 3 | 1998 | 424 | 0.210 |
Why?
|
Protein Stability | 2 | 2022 | 556 | 0.210 |
Why?
|
Interleukin-5 | 1 | 2022 | 273 | 0.200 |
Why?
|
Oncogenes | 2 | 2022 | 1265 | 0.200 |
Why?
|
Cytarabine | 3 | 2019 | 692 | 0.200 |
Why?
|
Paraneoplastic Syndromes | 1 | 2003 | 151 | 0.200 |
Why?
|
Septins | 1 | 2021 | 52 | 0.200 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2023 | 1736 | 0.200 |
Why?
|
Cytogenetic Analysis | 2 | 2013 | 295 | 0.200 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2022 | 114 | 0.200 |
Why?
|
Ubiquitins | 1 | 2023 | 384 | 0.200 |
Why?
|
Mice, SCID | 4 | 2021 | 2716 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 381 | 0.200 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2019 | 0.200 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 187 | 0.200 |
Why?
|
Loss of Heterozygosity | 3 | 2020 | 684 | 0.200 |
Why?
|
Mitochondria | 5 | 2019 | 3514 | 0.200 |
Why?
|
September 11 Terrorist Attacks | 1 | 2022 | 113 | 0.190 |
Why?
|
Histones | 4 | 2017 | 2598 | 0.190 |
Why?
|
RNA Helicases | 2 | 2020 | 142 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 227 | 0.190 |
Why?
|
Heme | 2 | 2013 | 307 | 0.190 |
Why?
|
Models, Molecular | 4 | 2020 | 5451 | 0.190 |
Why?
|
Gene Expression Regulation, Leukemic | 4 | 2022 | 651 | 0.190 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2021 | 215 | 0.190 |
Why?
|
Morpholines | 1 | 2024 | 571 | 0.190 |
Why?
|
Lysine | 2 | 2017 | 1007 | 0.190 |
Why?
|
U937 Cells | 1 | 2021 | 268 | 0.190 |
Why?
|
Welding | 1 | 2021 | 89 | 0.190 |
Why?
|
Blood Cell Count | 1 | 2021 | 403 | 0.190 |
Why?
|
RNA-Binding Proteins | 3 | 2017 | 1903 | 0.190 |
Why?
|
Cell Line | 15 | 2022 | 16000 | 0.190 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 310 | 0.190 |
Why?
|
Risk Factors | 16 | 2024 | 72296 | 0.190 |
Why?
|
Splenic Neoplasms | 1 | 2021 | 100 | 0.190 |
Why?
|
Alendronate | 1 | 2021 | 171 | 0.190 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2023 | 871 | 0.180 |
Why?
|
Carcinoma, Small Cell | 1 | 2003 | 420 | 0.180 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 2418 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.180 |
Why?
|
Dipeptides | 1 | 2022 | 409 | 0.180 |
Why?
|
Tissue Donors | 2 | 2020 | 2241 | 0.180 |
Why?
|
DNA Repair Enzymes | 1 | 2022 | 349 | 0.180 |
Why?
|
Oncogene Proteins | 2 | 2021 | 749 | 0.180 |
Why?
|
Dacarbazine | 1 | 2003 | 566 | 0.180 |
Why?
|
Cells, Cultured | 15 | 2021 | 19233 | 0.180 |
Why?
|
Interleukin-1beta | 2 | 2022 | 972 | 0.180 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 8 | 1998 | 70 | 0.180 |
Why?
|
Solvents | 1 | 2020 | 302 | 0.170 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 212 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 407 | 0.170 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2019 | 15 | 0.170 |
Why?
|
Wills | 1 | 2019 | 14 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2020 | 11525 | 0.170 |
Why?
|
Polycyclic Compounds | 1 | 2019 | 32 | 0.170 |
Why?
|
Cytokines | 5 | 2023 | 7323 | 0.170 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 180 | 0.170 |
Why?
|
Nephrotic Syndrome | 1 | 2003 | 389 | 0.170 |
Why?
|
Immunotherapy, Adoptive | 3 | 2024 | 1271 | 0.170 |
Why?
|
Menopause, Premature | 1 | 2020 | 132 | 0.170 |
Why?
|
Enhancer Elements, Genetic | 6 | 1998 | 1340 | 0.170 |
Why?
|
Lung Neoplasms | 6 | 2022 | 13104 | 0.170 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.170 |
Why?
|
Protein Binding | 7 | 2020 | 9384 | 0.170 |
Why?
|
Genotype | 6 | 2021 | 12952 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 903 | 0.170 |
Why?
|
Computational Biology | 3 | 2015 | 3519 | 0.170 |
Why?
|
Mass Spectrometry | 3 | 2020 | 2204 | 0.170 |
Why?
|
Disease Management | 3 | 2019 | 2460 | 0.160 |
Why?
|
RNA, Neoplasm | 3 | 2020 | 769 | 0.160 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2003 | 627 | 0.160 |
Why?
|
Gene Expression | 6 | 2016 | 7798 | 0.160 |
Why?
|
Air Pollutants, Occupational | 1 | 2021 | 408 | 0.160 |
Why?
|
Synthetic Biology | 1 | 2020 | 179 | 0.160 |
Why?
|
Serine | 1 | 2022 | 826 | 0.160 |
Why?
|
Phthalazines | 1 | 2021 | 363 | 0.160 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2010 | 1115 | 0.160 |
Why?
|
Lactams | 1 | 2019 | 156 | 0.160 |
Why?
|
Role | 1 | 2018 | 175 | 0.160 |
Why?
|
Myofibroblasts | 2 | 2017 | 222 | 0.160 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 465 | 0.160 |
Why?
|
GATA1 Transcription Factor | 1 | 2019 | 293 | 0.160 |
Why?
|
Etoposide | 4 | 2019 | 641 | 0.150 |
Why?
|
Duane Retraction Syndrome | 1 | 2018 | 60 | 0.150 |
Why?
|
Aged, 80 and over | 16 | 2022 | 57776 | 0.150 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 372 | 0.150 |
Why?
|
DNA Primers | 4 | 2014 | 2891 | 0.150 |
Why?
|
Osteoclasts | 1 | 2021 | 729 | 0.150 |
Why?
|
Survival Rate | 6 | 2022 | 12788 | 0.150 |
Why?
|
Disease Progression | 8 | 2023 | 13286 | 0.150 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 195 | 0.150 |
Why?
|
Receptors, GABA-A | 2 | 2001 | 627 | 0.150 |
Why?
|
Hydrolases | 1 | 2018 | 139 | 0.150 |
Why?
|
Sequence Analysis, DNA | 5 | 2018 | 4805 | 0.150 |
Why?
|
Immune System | 1 | 2023 | 806 | 0.150 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 576 | 0.150 |
Why?
|
Monosaccharide Transport Proteins | 2 | 1996 | 440 | 0.150 |
Why?
|
Blotting, Western | 4 | 2016 | 5181 | 0.150 |
Why?
|
Hydrazones | 1 | 2017 | 102 | 0.150 |
Why?
|
Zygote | 1 | 2017 | 116 | 0.150 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 70 | 0.150 |
Why?
|
Case-Control Studies | 6 | 2022 | 21748 | 0.150 |
Why?
|
Stromal Cells | 3 | 2011 | 1355 | 0.150 |
Why?
|
Excitatory Amino Acid Agonists | 4 | 1998 | 146 | 0.150 |
Why?
|
Colony-Forming Units Assay | 5 | 2020 | 356 | 0.150 |
Why?
|
Interleukins | 1 | 2021 | 791 | 0.150 |
Why?
|
Polymerase Chain Reaction | 3 | 2015 | 6171 | 0.140 |
Why?
|
Young Adult | 13 | 2022 | 56429 | 0.140 |
Why?
|
Alternative Splicing | 2 | 2019 | 1117 | 0.140 |
Why?
|
Stem Cells | 4 | 2023 | 3567 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 315 | 0.140 |
Why?
|
Uric Acid | 1 | 2022 | 766 | 0.140 |
Why?
|
Alanine | 3 | 1998 | 572 | 0.140 |
Why?
|
Genes, Dominant | 1 | 2019 | 880 | 0.140 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2023 | 691 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2019 | 15520 | 0.140 |
Why?
|
DNA Helicases | 2 | 2020 | 861 | 0.140 |
Why?
|
Neutropenia | 1 | 2021 | 895 | 0.140 |
Why?
|
Histone Demethylases | 1 | 2019 | 321 | 0.140 |
Why?
|
Species Specificity | 3 | 2018 | 2478 | 0.140 |
Why?
|
Introns | 1 | 2019 | 992 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2006 | 627 | 0.140 |
Why?
|
Gene Knockdown Techniques | 3 | 2016 | 1656 | 0.130 |
Why?
|
Germ Cells | 1 | 2020 | 631 | 0.130 |
Why?
|
Mice, Inbred BALB C | 5 | 2012 | 6386 | 0.130 |
Why?
|
Disasters | 1 | 2022 | 511 | 0.130 |
Why?
|
Macrophages | 4 | 2022 | 5660 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 548 | 0.130 |
Why?
|
Gene Knockout Techniques | 2 | 2016 | 808 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 323 | 0.130 |
Why?
|
Treatment Outcome | 11 | 2020 | 63107 | 0.130 |
Why?
|
Eosinophilia | 1 | 2020 | 541 | 0.130 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2014 | 21 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.130 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 727 | 0.130 |
Why?
|
Lentivirus | 2 | 2015 | 503 | 0.130 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2014 | 32 | 0.130 |
Why?
|
Myeloid Progenitor Cells | 2 | 2017 | 111 | 0.120 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2016 | 730 | 0.120 |
Why?
|
beta-Globins | 1 | 2015 | 115 | 0.120 |
Why?
|
Ubiquitin | 1 | 2020 | 851 | 0.120 |
Why?
|
Methylation | 1 | 2017 | 1106 | 0.120 |
Why?
|
Dimethyl Sulfoxide | 1 | 2015 | 249 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 2017 | 655 | 0.120 |
Why?
|
Genome | 3 | 2023 | 1807 | 0.120 |
Why?
|
Protein Conformation | 2 | 2022 | 4010 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2505 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2003 | 5223 | 0.120 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 70 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
Histocompatibility Antigens | 1 | 2015 | 471 | 0.120 |
Why?
|
Africa | 2 | 2020 | 672 | 0.120 |
Why?
|
Genes, ras | 1 | 2017 | 690 | 0.120 |
Why?
|
Immunity, Innate | 3 | 2016 | 2962 | 0.120 |
Why?
|
Protein Biosynthesis | 3 | 2012 | 2126 | 0.120 |
Why?
|
Age of Onset | 1 | 2020 | 3270 | 0.120 |
Why?
|
Heart Arrest | 1 | 2024 | 1470 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3590 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2014 | 365 | 0.120 |
Why?
|
HeLa Cells | 8 | 2020 | 3130 | 0.110 |
Why?
|
Cancer Vaccines | 1 | 2021 | 1023 | 0.110 |
Why?
|
Microscopy, Confocal | 3 | 2016 | 1970 | 0.110 |
Why?
|
GABA-A Receptor Agonists | 1 | 2013 | 84 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1276 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 988 | 0.110 |
Why?
|
Benzothiazoles | 2 | 2012 | 248 | 0.110 |
Why?
|
Oxygen | 7 | 2008 | 4189 | 0.110 |
Why?
|
Recurrence | 3 | 2022 | 8340 | 0.110 |
Why?
|
Amino Acid Sequence | 5 | 2018 | 13814 | 0.110 |
Why?
|
GTP-Binding Proteins | 2 | 2014 | 970 | 0.110 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 177 | 0.110 |
Why?
|
Nitriles | 1 | 2018 | 955 | 0.110 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2013 | 86 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1862 | 0.110 |
Why?
|
Promoter Regions, Genetic | 5 | 2019 | 5867 | 0.110 |
Why?
|
Thiazoles | 3 | 2014 | 1483 | 0.110 |
Why?
|
Mastocytosis, Systemic | 1 | 2014 | 100 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.110 |
Why?
|
Hematocrit | 2 | 2013 | 636 | 0.110 |
Why?
|
alpha-Globins | 1 | 2012 | 17 | 0.110 |
Why?
|
Syndrome | 2 | 2010 | 3252 | 0.110 |
Why?
|
History, 21st Century | 1 | 2018 | 1534 | 0.110 |
Why?
|
Gene Frequency | 2 | 2020 | 3587 | 0.100 |
Why?
|
Isoenzymes | 2 | 1996 | 1728 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
Receptors, GABA | 1 | 2013 | 287 | 0.100 |
Why?
|
Hypoxia-Inducible Factor 1 | 6 | 1998 | 198 | 0.100 |
Why?
|
Transplantation Chimera | 1 | 2014 | 613 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6486 | 0.100 |
Why?
|
Genome-Wide Association Study | 6 | 2021 | 12262 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2460 | 0.100 |
Why?
|
Up-Regulation | 3 | 2012 | 4222 | 0.100 |
Why?
|
Medical Oncology | 2 | 2020 | 2267 | 0.100 |
Why?
|
Leukocytes | 1 | 2020 | 2045 | 0.100 |
Why?
|
Pimozide | 1 | 2011 | 21 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2850 | 0.100 |
Why?
|
Phosphorylation | 6 | 2014 | 8436 | 0.100 |
Why?
|
Glutarates | 1 | 2013 | 236 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4666 | 0.100 |
Why?
|
Toluene | 1 | 2010 | 32 | 0.100 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2011 | 105 | 0.100 |
Why?
|
Pyrazoles | 2 | 2019 | 1972 | 0.100 |
Why?
|
Gene Targeting | 1 | 2014 | 880 | 0.100 |
Why?
|
Megakaryocyte-Erythroid Progenitor Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2110 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1793 | 0.090 |
Why?
|
Response Elements | 2 | 2010 | 312 | 0.090 |
Why?
|
Zebrafish Proteins | 2 | 2014 | 1005 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2013 | 225 | 0.090 |
Why?
|
Sequence Alignment | 1 | 2015 | 2256 | 0.090 |
Why?
|
Megakaryocyte Progenitor Cells | 1 | 2010 | 22 | 0.090 |
Why?
|
Treatment Failure | 2 | 2014 | 2618 | 0.090 |
Why?
|
Genetic Vectors | 3 | 2017 | 3424 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2740 | 0.090 |
Why?
|
Hemoglobins | 2 | 2013 | 1532 | 0.090 |
Why?
|
Neoplasm Transplantation | 5 | 2016 | 2086 | 0.090 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2010 | 36 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2019 | 491 | 0.090 |
Why?
|
Uniparental Disomy | 1 | 2010 | 43 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2073 | 0.090 |
Why?
|
STAT5 Transcription Factor | 1 | 2011 | 259 | 0.090 |
Why?
|
Cell Nucleolus | 1 | 2010 | 166 | 0.090 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 154 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 776 | 0.090 |
Why?
|
Prostaglandin D2 | 1 | 2010 | 122 | 0.090 |
Why?
|
Cobalt | 5 | 1996 | 158 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 508 | 0.090 |
Why?
|
Antigens, CD | 2 | 2010 | 4026 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 593 | 0.090 |
Why?
|
Sulfonamides | 3 | 2022 | 1940 | 0.090 |
Why?
|
Piperidines | 2 | 2019 | 1602 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3954 | 0.090 |
Why?
|
Tissue Scaffolds | 2 | 2016 | 956 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.090 |
Why?
|
Drosophila melanogaster | 2 | 2015 | 1708 | 0.090 |
Why?
|
Cytoplasmic Granules | 1 | 2012 | 610 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
World Health Organization | 3 | 2022 | 1318 | 0.090 |
Why?
|
Interleukin-2 | 2 | 2013 | 1904 | 0.090 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2008 | 16 | 0.080 |
Why?
|
Transfection | 6 | 2019 | 5895 | 0.080 |
Why?
|
Adolescent | 10 | 2022 | 85779 | 0.080 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2010 | 188 | 0.080 |
Why?
|
Organ Specificity | 4 | 2015 | 2008 | 0.080 |
Why?
|
Risk | 2 | 2021 | 9688 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1623 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39052 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2015 | 1580 | 0.080 |
Why?
|
Mitoxantrone | 2 | 2019 | 152 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1058 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2013 | 895 | 0.080 |
Why?
|
Deferoxamine | 4 | 1996 | 151 | 0.080 |
Why?
|
Trans-Activators | 1 | 1998 | 2926 | 0.080 |
Why?
|
Inhibitory Concentration 50 | 2 | 2016 | 459 | 0.080 |
Why?
|
Pyrrolidines | 1 | 2010 | 342 | 0.080 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2008 | 62 | 0.080 |
Why?
|
Cell Division | 2 | 2014 | 4569 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2014 | 931 | 0.080 |
Why?
|
NF-kappa B | 3 | 2018 | 2499 | 0.080 |
Why?
|
Luciferases | 2 | 2012 | 733 | 0.080 |
Why?
|
Stereoisomerism | 7 | 1999 | 624 | 0.080 |
Why?
|
beta Catenin | 1 | 2013 | 1059 | 0.080 |
Why?
|
Prevalence | 3 | 2021 | 15221 | 0.080 |
Why?
|
Drug Approval | 1 | 2014 | 742 | 0.080 |
Why?
|
Fibrosis | 1 | 2014 | 2029 | 0.080 |
Why?
|
5' Untranslated Regions | 1 | 2008 | 249 | 0.080 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2013 | 871 | 0.070 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 1941 | 0.070 |
Why?
|
Embryonic Development | 1 | 2012 | 711 | 0.070 |
Why?
|
Lipids | 1 | 2018 | 3307 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2012 | 971 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2012 | 1851 | 0.070 |
Why?
|
Casein Kinase II | 1 | 2007 | 128 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 2988 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3401 | 0.070 |
Why?
|
RNA, Ribosomal | 1 | 2008 | 245 | 0.070 |
Why?
|
Rats | 16 | 2019 | 24252 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 795 | 0.070 |
Why?
|
Spleen | 2 | 2010 | 2362 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 994 | 0.070 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2007 | 156 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4751 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2015 | 1373 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4479 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 689 | 0.070 |
Why?
|
Heterozygote | 2 | 2010 | 2804 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1880 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15078 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 378 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2010 | 1730 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5035 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 1999 | 794 | 0.060 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 1157 | 0.060 |
Why?
|
Homeostasis | 2 | 2014 | 3339 | 0.060 |
Why?
|
Proline | 1 | 2006 | 458 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6489 | 0.060 |
Why?
|
Genetic Testing | 2 | 2016 | 3444 | 0.060 |
Why?
|
Piperazines | 2 | 2016 | 2488 | 0.060 |
Why?
|
Stem Cell Factor | 1 | 2005 | 219 | 0.060 |
Why?
|
Energy Metabolism | 1 | 1996 | 2897 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4740 | 0.060 |
Why?
|
Algorithms | 2 | 2019 | 13882 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2624 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1420 | 0.060 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 1996 | 896 | 0.060 |
Why?
|
Imidazoles | 1 | 2010 | 1206 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2749 | 0.060 |
Why?
|
Protoporphyrins | 2 | 2003 | 164 | 0.060 |
Why?
|
Pedigree | 1 | 2012 | 4642 | 0.060 |
Why?
|
Genetic Complementation Test | 2 | 2017 | 562 | 0.060 |
Why?
|
Synapses | 1 | 2013 | 1728 | 0.060 |
Why?
|
Thrombocythemia, Essential | 1 | 2005 | 105 | 0.060 |
Why?
|
Child | 7 | 2023 | 77709 | 0.060 |
Why?
|
Acetates | 2 | 1996 | 311 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6896 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.060 |
Why?
|
Cell Line, Transformed | 1 | 2005 | 898 | 0.060 |
Why?
|
Dimerization | 2 | 2019 | 895 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1677 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2916 | 0.060 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2182 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7937 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2018 | 19905 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3280 | 0.060 |
Why?
|
Esophagus | 2 | 2014 | 1019 | 0.060 |
Why?
|
HIV | 1 | 2010 | 1604 | 0.060 |
Why?
|
Frameshift Mutation | 2 | 2019 | 399 | 0.060 |
Why?
|
Glucose | 1 | 2015 | 4398 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12961 | 0.050 |
Why?
|
Binding Sites | 3 | 2021 | 6111 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12356 | 0.050 |
Why?
|
Retroviridae | 1 | 2005 | 914 | 0.050 |
Why?
|
Tetraploidy | 1 | 2021 | 29 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11366 | 0.050 |
Why?
|
Bradycardia | 1 | 2024 | 307 | 0.050 |
Why?
|
Down-Regulation | 2 | 2011 | 3001 | 0.050 |
Why?
|
Proteoglycans | 2 | 2016 | 837 | 0.050 |
Why?
|
Prospective Studies | 4 | 2024 | 53290 | 0.050 |
Why?
|
Infant | 4 | 2022 | 35134 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1348 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2003 | 8861 | 0.050 |
Why?
|
Stem Cell Transplantation | 2 | 2023 | 1620 | 0.050 |
Why?
|
Cluster Analysis | 3 | 2015 | 2715 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2012 | 5023 | 0.050 |
Why?
|
Genetic Markers | 1 | 2008 | 2634 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Caspases, Initiator | 1 | 2021 | 32 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2001 | 128 | 0.050 |
Why?
|
Age Factors | 2 | 2015 | 18373 | 0.050 |
Why?
|
GABA Agonists | 1 | 2001 | 111 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
Homozygote | 3 | 2014 | 1787 | 0.050 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 1 | 2020 | 46 | 0.050 |
Why?
|
Carbocyanines | 1 | 2001 | 174 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2021 | 70 | 0.050 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 434 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 2960 | 0.050 |
Why?
|
Gases | 1 | 2021 | 197 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2703 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 23336 | 0.050 |
Why?
|
North America | 1 | 2024 | 1249 | 0.050 |
Why?
|
Iron | 1 | 2008 | 1774 | 0.050 |
Why?
|
Proteinuria | 1 | 2003 | 658 | 0.050 |
Why?
|
Caspase 1 | 1 | 2021 | 224 | 0.050 |
Why?
|
Fibroblasts | 1 | 2011 | 4162 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.050 |
Why?
|
Calmodulin | 1 | 2020 | 209 | 0.050 |
Why?
|
Zebrafish | 3 | 2020 | 2996 | 0.040 |
Why?
|
Odds Ratio | 2 | 2023 | 9849 | 0.040 |
Why?
|
Pentanoic Acids | 1 | 1999 | 15 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
Brain Stem Neoplasms | 1 | 2022 | 204 | 0.040 |
Why?
|
GABA Agents | 1 | 1999 | 42 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 297 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 596 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2020 | 121 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1939 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13409 | 0.040 |
Why?
|
Dizocilpine Maleate | 3 | 1994 | 176 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2017 | 1547 | 0.040 |
Why?
|
Xenopus | 1 | 2001 | 712 | 0.040 |
Why?
|
Bone and Bones | 1 | 2010 | 2576 | 0.040 |
Why?
|
Dust | 1 | 2022 | 482 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 314 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2008 | 1213 | 0.040 |
Why?
|
Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.040 |
Why?
|
Activating Transcription Factor 1 | 1 | 1998 | 26 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 1998 | 449 | 0.040 |
Why?
|
Crystallography, X-Ray | 4 | 1998 | 2012 | 0.040 |
Why?
|
Child, Preschool | 5 | 2022 | 41005 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8642 | 0.040 |
Why?
|
Baclofen | 1 | 1999 | 129 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Polycythemia | 1 | 1999 | 126 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2003 | 494 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12244 | 0.040 |
Why?
|
Mutant Proteins | 2 | 2013 | 500 | 0.040 |
Why?
|
Upper Extremity Deformities, Congenital | 1 | 2018 | 29 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2012 | 3702 | 0.040 |
Why?
|
Phosphoglycerate Kinase | 2 | 1996 | 68 | 0.040 |
Why?
|
Calcium Chloride | 1 | 1998 | 77 | 0.040 |
Why?
|
Myeloid Cells | 2 | 2018 | 810 | 0.040 |
Why?
|
Inhalation Exposure | 1 | 2021 | 443 | 0.040 |
Why?
|
Models, Genetic | 2 | 2007 | 3493 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Receptors, Metabotropic Glutamate | 2 | 1998 | 211 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 335 | 0.040 |
Why?
|
Caspase 8 | 1 | 2018 | 195 | 0.040 |
Why?
|
CREB-Binding Protein | 1 | 1998 | 151 | 0.040 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 165 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 386 | 0.040 |
Why?
|
Teratogens | 1 | 2018 | 112 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2019 | 209 | 0.040 |
Why?
|
Kainic Acid | 2 | 1997 | 199 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2019 | 246 | 0.040 |
Why?
|
Protein Subunits | 1 | 2001 | 959 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 16715 | 0.040 |
Why?
|
Allyl Compounds | 1 | 2017 | 23 | 0.040 |
Why?
|
Granulocytes | 2 | 2012 | 548 | 0.040 |
Why?
|
Receptors, Glutamate | 1 | 1998 | 232 | 0.040 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2017 | 35 | 0.040 |
Why?
|
Furans | 1 | 1998 | 194 | 0.040 |
Why?
|
Mice, Nude | 3 | 2012 | 3689 | 0.040 |
Why?
|
Granulocyte Precursor Cells | 1 | 2016 | 43 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1243 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2019 | 648 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 441 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2015 | 2012 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2022 | 850 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 2 | 2020 | 1988 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2022 | 1179 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1655 | 0.030 |
Why?
|
Kinetics | 2 | 2021 | 6476 | 0.030 |
Why?
|
Rotenone | 1 | 1995 | 43 | 0.030 |
Why?
|
Oocytes | 1 | 2001 | 1188 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7882 | 0.030 |
Why?
|
Glycine | 3 | 1994 | 671 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2021 | 25628 | 0.030 |
Why?
|
Onium Compounds | 1 | 1995 | 31 | 0.030 |
Why?
|
DNA | 2 | 2023 | 7294 | 0.030 |
Why?
|
Globins | 1 | 2017 | 416 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2013 | 10943 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
Ibotenic Acid | 2 | 1992 | 60 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Arecoline | 1 | 1995 | 9 | 0.030 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2001 | 721 | 0.030 |
Why?
|
Siderophores | 1 | 1996 | 57 | 0.030 |
Why?
|
Hemolymph | 1 | 2015 | 29 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14723 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2455 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 2015 | 111 | 0.030 |
Why?
|
Fat Body | 1 | 2015 | 32 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 427 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2005 | 2108 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1101 | 0.030 |
Why?
|
Mammography | 1 | 2006 | 2475 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 1995 | 193 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2017 | 892 | 0.030 |
Why?
|
Blood Vessels | 2 | 2014 | 1125 | 0.030 |
Why?
|
Melanoma | 1 | 2013 | 5511 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2018 | 478 | 0.030 |
Why?
|
Muscarinic Agonists | 1 | 1995 | 87 | 0.030 |
Why?
|
Brain | 7 | 2013 | 26388 | 0.030 |
Why?
|
Smoking | 2 | 2022 | 8987 | 0.030 |
Why?
|
Trehalose | 1 | 2015 | 88 | 0.030 |
Why?
|
Calcium Phosphates | 1 | 2016 | 171 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2069 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2020 | 20824 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 40559 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1995 | 821 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10259 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2001 | 1572 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 366 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1837 | 0.030 |
Why?
|
Multipotent Stem Cells | 1 | 2015 | 186 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 222 | 0.030 |
Why?
|
Electrophysiology | 4 | 1998 | 1308 | 0.030 |
Why?
|
Laminin | 1 | 2016 | 419 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 733 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 1995 | 249 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 2015 | 265 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1060 | 0.030 |
Why?
|
Drug Partial Agonism | 1 | 2013 | 24 | 0.030 |
Why?
|
Binding, Competitive | 4 | 1999 | 1157 | 0.030 |
Why?
|
Molecular Structure | 5 | 1997 | 1899 | 0.030 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2013 | 124 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 2014 | 255 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2428 | 0.030 |
Why?
|
Toll-Like Receptor 6 | 1 | 2013 | 28 | 0.030 |
Why?
|
Chelating Agents | 1 | 1995 | 380 | 0.030 |
Why?
|
raf Kinases | 1 | 2013 | 122 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2700 | 0.030 |
Why?
|
Toll-Like Receptor 1 | 1 | 2013 | 48 | 0.030 |
Why?
|
Adenine | 1 | 2019 | 936 | 0.030 |
Why?
|
Lovastatin | 1 | 2013 | 120 | 0.030 |
Why?
|
Mediator Complex | 1 | 2013 | 109 | 0.030 |
Why?
|
Calreticulin | 1 | 2014 | 98 | 0.030 |
Why?
|
Clodronic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1917 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1988 | 0.030 |
Why?
|
Receptors, Amino Acid | 1 | 1992 | 30 | 0.030 |
Why?
|
Ferrochelatase | 1 | 2012 | 46 | 0.030 |
Why?
|
Doxorubicin | 1 | 2019 | 2234 | 0.030 |
Why?
|
Cerebral Cortex | 5 | 1997 | 5709 | 0.030 |
Why?
|
Growth Substances | 1 | 1995 | 784 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2013 | 163 | 0.030 |
Why?
|
Cullin Proteins | 1 | 2013 | 181 | 0.030 |
Why?
|
TYK2 Kinase | 1 | 2012 | 38 | 0.030 |
Why?
|
Tyrphostins | 1 | 2012 | 67 | 0.030 |
Why?
|
Receptors, Kainic Acid | 3 | 1997 | 88 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2003 | 1585 | 0.030 |
Why?
|
Corpus Callosum | 1 | 1997 | 737 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2460 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2076 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2012 | 104 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2016 | 2646 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1723 | 0.030 |
Why?
|
Reticulocytes | 1 | 2013 | 290 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 2014 | 289 | 0.030 |
Why?
|
Blast Crisis | 1 | 2012 | 103 | 0.030 |
Why?
|
Anemia, Sideroblastic | 1 | 2012 | 101 | 0.030 |
Why?
|
Pericytes | 1 | 2014 | 293 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2016 | 1880 | 0.030 |
Why?
|
Acute Disease | 1 | 2022 | 7147 | 0.030 |
Why?
|
Glycolysis | 1 | 1996 | 829 | 0.030 |
Why?
|
Phenylalanine | 1 | 2013 | 365 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2428 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 150 | 0.020 |
Why?
|
N-Methylaspartate | 3 | 1997 | 231 | 0.020 |
Why?
|
Molecular Conformation | 3 | 1998 | 562 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 504 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 906 | 0.020 |
Why?
|
Valine | 1 | 2013 | 413 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 1995 | 913 | 0.020 |
Why?
|
Glutamic Acid | 1 | 1997 | 1169 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 354 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2034 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2014 | 599 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 77460 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1275 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1074 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 1416 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2018 | 1295 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2014 | 767 | 0.020 |
Why?
|
Recombination, Genetic | 2 | 2006 | 1586 | 0.020 |
Why?
|
Serpins | 1 | 2012 | 247 | 0.020 |
Why?
|
Tomography | 1 | 2012 | 390 | 0.020 |
Why?
|
Drug Combinations | 1 | 2016 | 1958 | 0.020 |
Why?
|
Propionates | 1 | 1991 | 169 | 0.020 |
Why?
|
Time Factors | 3 | 2013 | 40075 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 690 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2013 | 1137 | 0.020 |
Why?
|
Muscles | 1 | 2015 | 1614 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 2013 | 8300 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 894 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1420 | 0.020 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2010 | 132 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
Codon, Terminator | 1 | 2010 | 127 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2016 | 3144 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
Sarcoma, Myeloid | 1 | 2010 | 59 | 0.020 |
Why?
|
Erythrocytes | 1 | 2019 | 2455 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 2 | 2003 | 688 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 434 | 0.020 |
Why?
|
Stomach | 1 | 2014 | 697 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2013 | 957 | 0.020 |
Why?
|
Hematinics | 1 | 2012 | 280 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 8949 | 0.020 |
Why?
|
Endothelial Cells | 2 | 2014 | 3486 | 0.020 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 20 | 0.020 |
Why?
|
Iron-Regulatory Proteins | 1 | 2008 | 32 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3084 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1297 | 0.020 |
Why?
|
Antigens | 1 | 2014 | 1466 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3279 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2012 | 895 | 0.020 |
Why?
|
Osteogenesis | 1 | 2016 | 1299 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2008 | 53 | 0.020 |
Why?
|
Cortisone | 1 | 2008 | 89 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Metabolome | 1 | 2015 | 895 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5006 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2008 | 78 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2007 | 3773 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2010 | 275 | 0.020 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2009 | 281 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2009 | 272 | 0.020 |
Why?
|
Iron Chelating Agents | 1 | 2008 | 139 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2556 | 0.020 |
Why?
|
PC12 Cells | 1 | 2007 | 331 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 537 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2012 | 1549 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2688 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 296 | 0.020 |
Why?
|
Hydrogels | 1 | 2012 | 724 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 2184 | 0.020 |
Why?
|
United States | 3 | 2021 | 69872 | 0.020 |
Why?
|
Mesoderm | 1 | 2010 | 686 | 0.020 |
Why?
|
Staurosporine | 1 | 2007 | 251 | 0.020 |
Why?
|
Hydroxylation | 1 | 2006 | 141 | 0.020 |
Why?
|
Aorta | 1 | 2014 | 2062 | 0.020 |
Why?
|
RNA Stability | 1 | 2008 | 321 | 0.020 |
Why?
|
Mast Cells | 1 | 2014 | 1544 | 0.020 |
Why?
|
Health Personnel | 1 | 2020 | 3219 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2001 | 3508 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Multigene Family | 1 | 2010 | 1102 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1584 | 0.020 |
Why?
|
Thrombocytosis | 1 | 2006 | 81 | 0.020 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 98 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4446 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 225 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 721 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2006 | 262 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1701 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1063 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1881 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1839 | 0.020 |
Why?
|
Cycloheximide | 2 | 1996 | 347 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2003 | 6364 | 0.020 |
Why?
|
Hydrogen Bonding | 2 | 1996 | 291 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1741 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 1995 | 2638 | 0.020 |
Why?
|
Elasticity | 1 | 2006 | 657 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 1247 | 0.020 |
Why?
|
CHO Cells | 2 | 1998 | 1409 | 0.020 |
Why?
|
Cell Movement | 1 | 2016 | 5218 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2006 | 431 | 0.020 |
Why?
|
Osteoblasts | 1 | 2010 | 1166 | 0.020 |
Why?
|
Genetic Loci | 1 | 2013 | 2575 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3056 | 0.010 |
Why?
|
Memory | 1 | 2013 | 2174 | 0.010 |
Why?
|
Horseradish Peroxidase | 1 | 1983 | 166 | 0.010 |
Why?
|
Epidermis | 1 | 2006 | 528 | 0.010 |
Why?
|
Cricetinae | 2 | 1998 | 2475 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20952 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2715 | 0.010 |
Why?
|
Peroxidases | 1 | 1983 | 138 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3595 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1994 | 1085 | 0.010 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1983 | 115 | 0.010 |
Why?
|
Liver | 3 | 2007 | 7475 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9857 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3817 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 2005 | 434 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2010 | 3616 | 0.010 |
Why?
|
Aminolevulinic Acid | 1 | 2003 | 142 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5321 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3207 | 0.010 |
Why?
|
Metaplasia | 1 | 2003 | 313 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4583 | 0.010 |
Why?
|
Circular Dichroism | 2 | 1998 | 354 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1640 | 0.010 |
Why?
|
Organ Size | 1 | 2006 | 2251 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2001 | 6773 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6311 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1983 | 419 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12746 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2008 | 1826 | 0.010 |
Why?
|
Liver Neoplasms | 4 | 2001 | 4253 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4372 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4851 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5984 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Mitosis | 1 | 2005 | 1208 | 0.010 |
Why?
|
Hepatocytes | 1 | 2006 | 1211 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 1983 | 730 | 0.010 |
Why?
|
Synaptic Membranes | 1 | 1999 | 91 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7282 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9955 | 0.010 |
Why?
|
Receptors, GABA-B | 1 | 1999 | 68 | 0.010 |
Why?
|
Anxiety | 1 | 2013 | 4293 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1999 | 374 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3255 | 0.010 |
Why?
|
Photosensitizing Agents | 1 | 2003 | 602 | 0.010 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 86 | 0.010 |
Why?
|
Potentiometry | 1 | 1997 | 10 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2008 | 2585 | 0.010 |
Why?
|
Photochemistry | 1 | 1998 | 238 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 3 | 1995 | 2214 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3690 | 0.010 |
Why?
|
Anticonvulsants | 2 | 1998 | 1916 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1999 | 1386 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 2001 | 403 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.010 |
Why?
|
Serum Albumin | 1 | 1980 | 675 | 0.010 |
Why?
|
Ileum | 1 | 1999 | 565 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1996 | 101 | 0.010 |
Why?
|
Endocytosis | 1 | 2001 | 985 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2008 | 1911 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4424 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2304 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2308 | 0.010 |
Why?
|
Body Weight | 1 | 2006 | 4671 | 0.010 |
Why?
|
RNA, Small Nuclear | 1 | 1995 | 65 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2003 | 1534 | 0.010 |
Why?
|
DNA Probes | 1 | 1996 | 560 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1999 | 934 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1995 | 156 | 0.010 |
Why?
|
TATA Box | 1 | 1994 | 128 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1995 | 708 | 0.010 |
Why?
|
Cyanides | 1 | 1994 | 83 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1999 | 1235 | 0.010 |
Why?
|
Pregnancy Proteins | 1 | 1995 | 229 | 0.010 |
Why?
|
3T3 Cells | 1 | 1995 | 1101 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1995 | 772 | 0.010 |
Why?
|
Intestines | 1 | 2003 | 1924 | 0.010 |
Why?
|
Deoxyribonuclease I | 1 | 1994 | 229 | 0.010 |
Why?
|
Angiogenesis Inducing Agents | 1 | 1995 | 282 | 0.010 |
Why?
|
Ultrasonography | 1 | 2006 | 5984 | 0.010 |
Why?
|
Thermodynamics | 1 | 1994 | 594 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2001 | 2924 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1995 | 625 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 1995 | 694 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2007 | 3143 | 0.010 |
Why?
|
Lymphokines | 1 | 1995 | 949 | 0.010 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 1983 | 165 | 0.010 |
Why?
|
Evoked Potentials | 1 | 1997 | 1056 | 0.010 |
Why?
|
Neurons | 1 | 1991 | 9340 | 0.010 |
Why?
|
Biological Evolution | 1 | 1997 | 1077 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2007 | 4262 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6755 | 0.010 |
Why?
|
Tritium | 1 | 1991 | 745 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1991 | 462 | 0.010 |
Why?
|
Autoradiography | 1 | 1991 | 745 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2001 | 2727 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2186 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3476 | 0.010 |
Why?
|
Drosophila | 1 | 1997 | 1491 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1994 | 4320 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1995 | 2007 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3759 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6621 | 0.000 |
Why?
|
Cell Membrane | 1 | 1994 | 3749 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1995 | 3511 | 0.000 |
Why?
|
Aminopyrine | 1 | 1983 | 8 | 0.000 |
Why?
|
Spectrophotometry, Infrared | 1 | 1980 | 114 | 0.000 |
Why?
|
Protein Denaturation | 1 | 1980 | 237 | 0.000 |
Why?
|
Viscosity | 1 | 1980 | 328 | 0.000 |
Why?
|
Disulfides | 1 | 1980 | 457 | 0.000 |
Why?
|
Rabbits | 1 | 1983 | 4894 | 0.000 |
Why?
|
Cysteine | 1 | 1980 | 873 | 0.000 |
Why?
|
Temperature | 1 | 1980 | 2204 | 0.000 |
Why?
|